SPOORTHY CHALLA: Open Payments
NPI 1457827651 · LANSDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 33 payments from 11 companies in 2025. Trend: 2023 $199 · 2024 $677 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $264 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $161 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $106 |
| Novo Nordisk Inc | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: ELIQUIS, JARDIANCE, LifeVest, Wegovy, LEQVIO, CAMZYOS, FARXIGA, VERQUVO.
Industry payments across PA — which companies pay providers there.
